Download Library

Share this on: Delicious Digg Facebook LinkedIn Twitter What is this?

Quickly sort and find the exact file you need here. Send the files directly into your Shareholder Briefcase or read and right click "save target as" individual files.

Title	Date	Type	Size
VinCRIStine Sulfate LIPOSOME Injection (VSLI, Marqibo ®) Facilitates Increased Delivery of Vincristine Sulfate to Target Cancer Tissues	12/10/2012		204.2 KB
Neurotoxicity Profile of VinCRIStine Sulfate LIPOSOME Injection (VSLI, Marqibo ®) Monotherapy in Adults with Relapse Acute Lymphoblastic Leukemia and Universal Prior Standard Vincristine Exposure	12/10/2012		140.2 KB
Talon Therapeutics Corporate Presentation			1.6 MB
Single-Agent Vincristine Sulfate Liposomes Injection (Marqibo®) Compared to Historical Single-Agent Therapy for Adults with Advanced, Relapsed and/or Refractory Philadelphia Chromosome Negative Acute Lymphoblastic Leukemia	12/11/2011		147.7 KB
2010_10-K.pdf			896.3 KB
VSLI (Vincristine Sulfate Liposomes Injection, Marqibo®) "Bridging" to Potentially Curative Hematopoietic Stem Cell Transplantation (HSCT) in Adults with Philadelphia Chromosome Negative (PH-) Acute Lymphoblastic Leukemia (ALL)	06/09/2011		151.1 KB
Code of Conduct			30.1 KB
Whistle Blower			N/A
VSLI (vincristine sulfate liposomes injection) in the Treatment of Adult Subjects with Advanced, Relapsed/Refractory Acute Lymphoblastic Leukemia (ALL): A Combined Analysis of the VSLI-06 and rALLy Studies	12/05/2010		110.6 KB
Marqibo (vincristine sulfate liposomes injection; VSLI) Optimizes the Dosing, Delivery, and Pharmacokinetic (PK) Profile of Vincristine Sulfate (VCR) in Adults with Relapsed and Refractory Acute Lymphoblastic Leukemia (ALL)	12/05/2010		116.9 KB
Showing 1-10 of 33 Page: 1 2 3 4  Next 10

Investors

Stock Information

Shareholder Tools

Search IR